Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Faaborg Pharma - IP ApS
APS
Active
CVR 43517252
Markedspladsen 13A
Leasing of intellectual property and similar products, except copyrighted works · NACE 7740
Est. 2022
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
DKK -248K
-6% vs 2023
EBITDA margin
100.0%
+6% vs 2023
Equity ratio
-55.6%
Financial strength
Net profit 2024
DKK -895K
-18% vs 2023
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
DKK -248K
-6%
EBITDA
DKK -248K
+6%
Net profit
DKK -895K
-18%
Total assets
DKK 2,9M
-1%
Equity
DKK -1,6M
-125%
Employees
—
—
Company information
Legal name
Faaborg Pharma - IP ApS
CVR number
43517252
Legal form
Anpartsselskab
NACE code
7740 · Leasing of intellectual property and similar products, except copyrighted works
Founded
12. september 2022
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren alene eller af den samlede bestyrelse.
Company purpose
Selskabets formål er handel samt anden hermed beslægtet virksomhed.
Contact
Address
Markedspladsen 13A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Leasing of intellectual property and similar products, except copyrighted works
Companies in Faaborg-Midtfyn
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
DKK thousands
Item
2023
2024
Revenue
-264
-248
Staff expenses
-0
-0
EBITDA
-264
-248
Depreciation & amort.
-550
-663
EBIT
-814
-910
Net financials
-121
-236
Profit before tax
-935
-1.146
Tax
-177
-251
Net profit
-758
-895
Balance sheet
DKK thousands
Item
2023
2024
Total assets
2.929
2.899
Equity
-718
-1.613
Long-term debt
0
0
Short-term debt
3.647
4.512
Total debt
3.647
4.512
Financial ratios
5-year trend
EBITDA margin
-24766500.0%
This company
15.8%
Market median
-156750100% vs market
2023
2024
Equity ratio
-55.6%
This company
38.2%
Market median
-246% vs market
2023
2024
Return on equity
-89535600.0%
This company
18.4%
Market median
-486606622% vs market
2023
2024
Net profit margin
-89535600.0%
This company
8.1%
Market median
-1105377878% vs market
2023
2024
Asset turnover
-0.09×
This company
1.12×
Market median
-108% vs market
2023
2024
Debt / equity
2.80×
This company
0.62×
Market median
-352% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-09-12 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JK
Jan Knudsen
Management
Management
2022
—
—
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
BS
Birk Simon Maldonado Andersen
Board of Directors
2022
—
—
CW
Claus Wædeled
Chairman
2022
—
—
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Faaborg Løve Produkter Holding I ApS
Company
100.0%
100.0%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
FAABORG LØVE PRODUKTER HOLDING ApS
Faaborg Løve Produkter Holding I ApS
Faaborg Pharma - IP ApS
(this company)
Board network connections
Board members of Faaborg Pharma - IP ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jan Knudsen
Management
0 companies
Birk Simon Maldonado Andersen
Board of Directors
0 companies
Claus Wædeled
Chairman
0 companies